YOLFTbeta
00

Tianjin Lisheng Pharmaceutical Co Ltd

002393 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

12.47CNY-0.20 (-1.58%)

Price History

Full chart

Market Stats

Previous Close12.67
Open12.64
Day Range12.44 – 12.68
52-Week Range13.31 – 19.67
Volume1.21M
Market Cap4.34B
P/E (TTM)28.73
Forward P/E14.73
EPS0.49
Dividend Yield8.11%
Beta-0.07
50-Day Avg14.19
200-Day Avg16.44

About

Tianjin Lisheng Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company offers pharmaceutical, traditional Chinese medicine, and antibiotic products in various forms, such as oral solid dosage forms, soft capsules, sterile preparations, and raw materials primarily for cardiovascular and digestive system applications. Its products also include Shoubishan capsules, Jiayindapamide tablets, Sanyu Zhengtong tablets, Xifuni cefdinir dispersible tablets, and Youhao Maren soft capsules. In addition, the company provides pharmaceutical manufacturing outsourcing services and technology research and development services. Further, it exports its products. The company was founded in 1951 and is headquartered in Tianjin, China. Tianjin Lisheng Pharmaceutical Co.,Ltd. operates as a subsidiary of Tianjin Jinhao Pharmaceutical Co., Ltd.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Fujun Wang
  • Employees1.60K
  • HeadquartersNo.16, Saida North 1st Road, Tianjin, China, 300385, China
  • Websitehttps://www.lishengpharma.com

Leadership

  • Mr. Fujun WangGM & Non-Independent Director · b. 1967
  • Mr. Jiaying WangFinancial Director · b. 1981
  • Ms. Feifei MaSecretary of the Board · b. 1980
  • Mr. Changfeng LongChief Engineer & Deputy GM · b. 1974
  • Mr. Jiankang LiangDeputy General Manager · b. 1973
  • Ms. Xiaoyan GuoDeputy General Manager · b. 1973
  • Gao JunAccounting Supervisor

Financials

Income Statement

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue349.44M393.29M592.54M595.70M737.97M763.64M1.12B1.04B773.73M774.78M846.85M1.03B1.50B1.62B1.14B1.09B1.15B1.15B1.34B1.39B
Growth (%)-+12.55%+50.66%+0.53%+23.88%+3.48%+46.28%-6.51%-25.92%+0.14%+9.30%+21.56%+46.06%+7.43%-29.37%-4.29%+5.00%+0.56%+15.88%+4.23%
Cost of Revenue105.90M119.93M241.41M218.28M295.39M299.50M431.43M370.51M351.96M344.52M369.16M387.76M438.90M465.55M456.50M473.95M510.51M487.97M624.04M647.52M
Gross Profit243.54M273.37M351.13M377.42M442.59M464.15M685.64M673.89M421.77M430.26M477.69M641.67M1.06B1.15B684.34M618.00M636.08M665.06M712.11M1.39B
Gross Margin69.69%69.51%59.26%63.36%59.97%60.78%61.38%64.52%54.51%55.53%56.41%62.33%70.81%71.18%59.99%56.60%55.48%57.68%53.30%100.00%
Operating Expense126.29M118.63M178.76M182.14M181.07M78.14M366.77M330.99M313.99M296.64M346.40M511.04M849.70M929.58M653.31M481.09M518.01M245.26M490.46M922.71M
Operating Income117.25M154.74M172.37M195.28M261.52M386.01M318.86M342.90M107.78M133.62M131.29M130.63M215.01M220.15M31.03M136.91M118.06M419.81M221.65M469.96M
Operating Margin33.55%39.34%29.09%32.78%35.44%50.55%28.54%32.83%13.93%17.25%15.50%12.69%14.30%13.63%2.72%12.54%10.30%36.41%16.59%33.75%
EBITDA104.89M169.87M198.06M225.02M285.13M406.12M388.14M372.34M140.29M162.78M184.88M190.80M271.66M278.93M94.94M196.72M184.44M487.52M296.46M533.40M
EBITDA Margin30.02%43.19%33.43%37.77%38.64%53.18%34.75%35.65%18.13%21.01%21.83%18.53%18.07%17.27%8.32%18.02%16.09%42.28%22.19%38.30%
Net Income100.23M132.45M132.01M154.51M203.40M324.77M297.11M292.99M92.88M114.21M115.61M116.82M184.98M188.14M8.62M122.11M93.61M361.83M184.53M418.37M
Net Income Margin28.68%33.68%22.28%25.94%27.56%42.53%26.60%28.05%12.00%14.74%13.65%11.35%12.30%11.65%0.76%11.18%8.16%31.38%13.81%30.04%
R&D-12.98M17.31M17.63M23.31M25.49M40.62M39.29M41.49M33.23M64.21M102.19M94.30M123.43M76.70M104.09M105.98M105.62M126.76M115.19M
R&D as % of Total Revenue-3.30%2.92%2.96%3.16%3.34%3.64%3.76%5.36%4.29%7.58%9.93%6.27%7.64%6.72%9.53%9.24%9.16%9.49%8.27%
Interest Expense4.86M5.88M8.47M4.33M2.02M249.03K55.60K244.83K2.40M1.98M2.77M3.79M2.88M1.54M737.26K320.50K875.18K876.40K3.55M2.87M
Interest Expense % of Total Revenue1.39%1.49%1.43%0.73%0.27%0.03%0.00%0.02%0.31%0.26%0.33%0.37%0.19%0.10%0.06%0.03%0.08%0.08%0.27%0.21%

Balance Sheet

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets863.49M874.11M745.35M882.13M2.73B2.86B2.93B3.22B3.25B3.41B3.49B3.68B3.92B5.27B5.02B5.19B5.29B5.78B5.79B5.58B
Total Liabilities415.03M441.87M270.58M411.26M77.12M64.07M148.13M298.20M337.89M439.50M470.60M602.32M704.85M855.85M720.09M780.42M941.66M877.17M985.54M890.89M
Total Equity417.86M401.39M432.49M416.84M2.63B2.79B2.77B2.92B2.91B2.97B3.02B3.08B3.21B4.42B4.30B4.41B4.35B4.90B4.77B4.63B
Cash171.15M192.15M120.11M267.70M2.04B1.93B1.36B1.36B1.05B980.68M872.19M1.48B1.55B1.69B1.56B1.65B1.79B1.99B1.64B1.54B
Total Debt151.25M209.03M165.87M180.00M20.00M-8.04M138.00M110.00M100.00M91.43M90.01M81.22M26.92M19.16M34.74M45.08M32.55M48.17M173.90M
Net Debt-19.90M16.88M45.76M-87.70M-2.02B-1.93B-1.35B-1.23B-944.71M-880.68M-780.76M-1.39B-1.47B-1.67B-1.54B-1.62B-1.75B-1.96B-1.59B-1.36B

Cash Flow

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-174.94M126.59M196.14M186.55M134.58M250.72M289.62M72.24M198.13M173.60M179.25M162.69M268.33M76.37M196.34M331.38M209.51M88.26M451.85M
Investing Cash Flow75.12M-94.22M-10.67M-14.82M-108.21M-49.40M-204.84M-257.01M-277.12M-173.98M-186.47M495.22M-63.88M-66.05M-92.92M-76.12M-155.64M19.36M-259.09M-371.64M
Financing Cash Flow-57.90M-59.72M-187.96M-33.74M1.70B-205.59M-659.68M-25.56M-135.39M-67.51M-104.68M-63.28M-92.29M-65.90M-75.06M-18.25M-33.79M-48.82M-174.18M-138.14M
Capital Expenditure30.82M13.92M64.86M17.60M69.69M165.94M224.35M313.11M290.65M204.60M137.20M50.09M104.43M90.46M100.66M88.24M40.91M61.72M53.75M37.46M
Free Cash Flow-30.82M161.02M61.73M178.55M116.87M-31.36M26.38M-23.49M-218.41M-6.47M36.40M129.16M58.26M177.87M-24.29M108.10M290.47M138.29M34.51M414.39M
Dividends Paid32.78M107.50M144.80M47.87M150.69M164.49M157.96M162.07M111.54M58.34M77.20M58.28M57.29M54.74M54.74M18.25M54.74M54.74M121.03M89.69M
FCF to OCF-92.04%48.76%91.03%62.64%-23.30%10.52%-8.11%-302.34%-3.27%20.97%72.05%35.81%66.29%-31.81%55.06%87.65%66.01%39.10%91.71%
Dividend Paid to FCF-106.33%66.76%234.58%26.81%128.94%-524.54%598.87%-689.88%-51.07%-901.10%212.11%45.13%98.33%30.77%-225.31%16.88%18.84%39.58%350.68%21.64%

Earnings

Report DateJun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 28, 2020Aug 24, 2020Oct 27, 2020Mar 24, 2021Apr 28, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Dec 29, 2023Dec 31, 2023May 28, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 16, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------------------------------------------------------
EPS Actual0.230.160.080.550.240.150.130.330.280.230.140.350.340.200.090.210.100.04-0.050.150.190.04-0.020.140.090.030.120.130.120.070.050.130.090.120.260.140.140.150.170.190.120.12-0.390.200.080.120.080.140.100.13-0.060.150.141.380.060.320.140.220.050.220.940.090.150.170.09
Surprise-----------------------------------------------------------------
Timing-----------------------------------------------------After-hours-After-hours---After-hours-----

Key Statistics & Ratios

Market Cap4.34B
Enterprise Value2.01B
Trailing P/E28.73
Forward P/E14.73
PEG Ratio0.00
Price / Sales3.33
Price / Book0.96
EPS0.49
Book Value14.23
Revenue (TTM)1.30B
Gross Profit (TTM)673.05M
EBITDA184.21M
Profit Margin11.65%
Operating Margin6.99%
Return on Equity3.30%
Return on Assets1.25%
Shares Outstanding308.29M
Shares Float148.20M
Beta-0.07
Dividend Yield8.11%
Dividend Rate1.14
Payout Ratio1.70%

Dividends

20262×
0.60Apr 28, 20260.25Feb 11, 2026
20251×
0.29Apr 29, 2025
20241×
0.36May 28, 2024
20231×
0.18Jun 30, 2023
20221×
0.18Jun 20, 2022
20211×
0.06Jun 11, 2021
20201×
0.18Jul 8, 2020
20191×
0.18Jun 13, 2019
20181×
0.18Jun 12, 2018
20171×
0.18Jun 8, 2017
20161×
0.24May 30, 2016
20151×
0.18May 18, 2015
20141×
0.36Jun 27, 2014
20131×
0.48Jul 11, 2013
20121×
0.54Jun 29, 2012
20111×
0.54Apr 21, 2011

Stock Splits

  • Apr 28, 20261.2:1
  • May 28, 20241.4:1